Global Liver Institute

On the second Thursday in June, Global Fatty Liver Day (formerly International NASH Day) spotlights one of the most widespread yet under-addressed health threats of our time: fatty liver disease, increasingly referred to as steatotic liver disease (SLD) in clinical settings. Hosted annually by Global Liver Institute (GLI), this public awareness campaign raises awareness of this silent epidemic and its deep roots in global metabolic health challenges.

Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act, which was recently introduced by Senators Bill Cassidy (R-LA) and Ben Ray Luján (D-NM).

Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to implement a nationwide elimination program for the hepatitis C virus (HCV) in the United States.

Global health leaders call for urgent, integrated action on the rising rates of metabolic liver disease during a high-level policy event held on the sidelines of the 78th World Health Assembly and co-hosted by Global Liver Institute (GLI), the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD).

Leading health organizations, policymakers, and public health advocates will come together during the 78th World Health Assembly (WHA78) for a pivotal side event titled “Together for Better Liver Health – Strengthening Public Health Responses to Metabolic Disease”.

Chronic infection of the liver by hepatitis B virus (HBV) remains a significant public health concern in the U.S. and around the world, particularly among at-risk populations.